| ¿µ¹® | catecholamine | ÇÑ±Û | Ä«Å×Äݶó¹Î |
|---|---|---|---|
| ¼³¸í | ±³°¨½Å°æÀÇ ÀÛ¿ëÀ» Ç×Áø½Ãų ¼ö°¡ ÀÖ´Â ÀÏ·ÃÀÇ ÈÇÕ¹°ÀÌ´Ù. ºÐÀÚÀÇ ¹æÇâÁ· ºÎºÐÀº Ä«Å×ÄÝ, Áö¹æÁ· ºÎºÐÀº ¾Æ¹ÎÀ¸·Î µÇ¾î ÀÖ´Ù. ÀÌ·¯ÇÑ ÈÇÕ¹°¿¡´Â µµÆÄ¹Î, ³ë¸£¿¡Çdz×ÇÁ¸°, ¿¡Çdz×ÇÁ¸°ÀÌ ÀÖÀ¸¸ç ÀÌ ¼¼ °¡Áö´Â ºÐÆ÷, »ý¸®ÀÛ¿ë µî¿¡¼ °¢°¢ ´Ù¸¥ Ư¡À» °¡Áø´Ù. |
||
| AChRs | Acetylcholine Receptors |
|---|---|
| RA | radioactive; ragocyte; ragweed antigen; rapidly adapting [receptors]; reactive arthritis; reciprocal... |
| CA | anterior commissure [Lat. commissura anterior]; calcium antagonist; California [rabbit]; cancer; Can... |
| CAT | California Achievement Test; capillary agglutination test; catalase; cataract; catecholamine; Childr... |
| COMT | catecholamine O-methyl transferase; certified ophthalmic medical technologist |
| CA | Catecholamine |
|---|---|
| CAT | Catecholamine |
| AR | Alpha1-adrenergic receptors |
| alpha1-ARs | Alpha1-adrenergic receptors |
| beta 2AR | Beta 2-adrenergic receptors |
| receptors, catecholamine | Cell surface proteins that bind catecholamines with high affinity and trigger intracellular changes which influence the behaviour of cells. The catecholamine messengers epinephrine, norepinephrine, and dopamine are synthesised from tyrosine by a common biosynthetic pathway. (12 Dec 1998) |
|---|
| blood catecholamine | <investigation> The measurement of noradrenaline and adrenaline in the blood. Often these same catecholamines can be measured in the urine. Elevations may be seen in pheochromocytoma or neuroblastoma. Normal blood levels of adrenaline should be: 20 ng/ml and normal blood levels of noradrenaline should be 60 ng/ml. (05 Jan 1998) |
|---|---|
| catecholamine | <biochemistry, investigation, physiology> A type of biogenic amine derived from tyramine, characterised as alkylamino derivatives of ortho-dihydroxyphenylalkylamines in turn derived from tyrosine. Catecholamines include adrenaline, noradrenaline and dopamine, with roles as hormones and neurotransmitters. Measurement of noradrenaline and adrenaline can be made in blood and urine. Elevations may be seen in pheochromocytoma or neuroblastoma. Normal blood levels of adrenaline should be: 20 ng/ml and normal blood levels of noradrenaline should be 60 ng/ml. (16 Mar 1998) |
| total catecholamine test | A fluorometric determination of catecholamines in 24-hr urine specimens; elevated values are seen in patients with pheochromocytoma and neuroblastoma; spurious elevations may be seen due to excretion products of medication containing adrenaline, tetracyclines, quinidine, and some antihypertensive agents; false-positive elevations may be seen in persons with extensive burns, in vigorous exercise, or in progressive muscular dystrophy. (05 Mar 2000) |
| urine catecholamine | A test that measures the level of catecholamines or their metabolites in the urine. A 24 hour urine sample is necessary for this assay. Elevations may be seen in pheochromocytoma or neuroblastoma. Normal urine levels of adrenaline should be: 0.5 to 20 mcg/ml and normal urine levels of noradrenaline should be 15 to 80 mcg/ml. (27 Sep 1997) |
| adrenergic receptors | Reactive components of effector tissues, most of which are innervated by adrenergic postganglionic fibres of the sympathetic nervous system. Such receptor's can be activated by norepinephrine and/or epinephrine and by various adrenergic drugs; receptor activation results in a change in effector tissue function, such as contraction of arteriolar muscles or relaxation of bronchial muscles; adrenergic receptor's are divided into alpha-receptor's and beta-receptor's, on the basis of their response to various adrenergic activating and blocking agents. Synonym: adrenoceptor, adrenoreceptors. (05 Mar 2000) |
| alpha-adrenergic receptors | Adrenergic receptor's in effector tissues capable of selective activation and blockade by drugs; conceptually derived from the ability of certain agents, such as phenoxybenzamine, to block only some adrenergic receptor's and of other agents, such as methoxamine, to activate only the same adrenergic receptor's. Such receptor's are designated as alpha-receptors. Their activation results in physiological responses such as increased peripheral vascular resistance, mydriasis, and contraction of pilomotor muscles. (05 Mar 2000) |
| ANP clearance receptors | Cell surface proteins that bind atrial natriuretic peptide and ANP fragments without initiating biological action. (05 Mar 2000) |
| ANP receptors | Cell surface receptors for atrial natriuretic peptide that have a single transmembrane spanning element; these have integral kinase and guanylate cyclase domains. (05 Mar 2000) |
| B-cell antigen receptors | In the primary immune response immunoglobulin D and monomeric immunoglobulin M are the B-cell antigen receptors. On memory B-cells, other immunoglobulin molecules can serve as antigen receptors. (05 Mar 2000) |
| beta-adrenergic receptors | Adrenergic receptor's in effector tissues capable of selective activation and blockade by drugs; conceptually derived from the ability of certain agents, such as propranolol, to block only some adrenergic receptor's and of other agents, such as isoproterenol, to activate only the same adrenergic receptor's. Such receptor's are designated as beta-receptors. Their activation results in physiological responses such as increases in cardiac rate and force of contraction (b1), and relaxation of bronchial and vascular smooth muscle (b2). (05 Mar 2000) |
| mannose-6-phosphate receptors | Receptors in Golgi apparatus to which newly synthesised proteins that are destined to enter lysosomes bind. (05 Mar 2000) |
| receptors, adrenergic | Cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. Adrenergic receptors may also be classified according to the subtypes of g-proteins with which they bind; this scheme does not respect the alpha-beta distinction. (12 Dec 1998) |
| receptors, adrenergic, alpha | One of the two major pharmacological subdivisions of adrenergic receptors. The alpha-beta distinction was originally based on cellular effects of receptor activation but now relies on the relative affinities for certain synthetic ligands. Alpha-adrenergic receptors are further subdivided into several subclasses based on studies of endogenous and cloned receptors. (12 Dec 1998) |
| receptors, adrenergic, alpha-1 | A subclass of alpha-adrenergic receptors (receptors, adrenergic, alpha). Alpha-1 adrenergic receptors can be pharmacologically discriminated, e.g., by their high affinity for the agonist phenylephrine and the antagonist prazosin. They are widespread, with clinically important concentrations in the liver, the heart, vascular, intestinal, and genitourinary smooth muscle, and the central and peripheral nervous systems. (12 Dec 1998) |
| receptors, adrenergic, alpha-2 | A subclass of alpha-adrenergic receptors (receptors, adrenergic, alpha). Alpha-2 adrenergic receptors can be pharmacologically discriminated, e.g., by their high affinity for the agonist clonidine and the antagonist yohimbine. They are found on pancreatic beta cells, platelets, and vascular smooth muscle, as well as both pre- and postsynaptically in the central and peripheral nervous systems. (12 Dec 1998) |
Synonyms : Catecholamine Receptor, Receptors, Catecholamines, Catecholamines Receptors, Receptor, Catecholamine
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|